Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-15 · accession 0001662579-24-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-15 | 2024-02-15 | CCCC | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $7.90 | -6,560 | 210.7K | -3% | -$51.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | F | D | 6,560 | $7.90 | 210,741 | D | — | — |